UnitedHealth Group (NYSE:UNH) Trading 0.1% Higher

UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) was up 0.1% during mid-day trading on Wednesday . The stock traded as high as $507.00 and last traded at $501.65. Approximately 831,837 shares were traded during mid-day trading, a decline of 81% from the average daily volume of 4,337,228 shares. The stock had previously closed at $500.96.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on UNH shares. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $600.00 to $525.00 and set an "overweight" rating on the stock in a report on Monday, April 8th. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $545.00 to $562.00 and gave the company a "buy" rating in a research report on Friday, April 19th. Truist Financial restated a "buy" rating and set a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Bank of America reissued a "buy" rating and set a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Finally, TD Cowen dropped their target price on UnitedHealth Group from $607.00 to $546.00 and set a "buy" rating on the stock in a report on Wednesday, April 10th. Four analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus price target of $570.05.

UnitedHealth Group Stock Performance

The stock has a market cap of $462.99 billion, a P/E ratio of 30.76, a P/E/G ratio of 1.43 and a beta of 0.55. The company has a fifty day moving average price of $481.45 and a 200 day moving average price of $511.98. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business's revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the company posted $6.26 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.49%. The ex-dividend date was Friday, March 8th. UnitedHealth Group's payout ratio is 45.97%.

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company's stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm's stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company's stock, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the company's stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

Institutional Trading of UnitedHealth Group

Institutional investors have recently bought and sold shares of the company. Texas Capital Bancshares Inc TX raised its stake in UnitedHealth Group by 1.1% during the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate's stock worth $855,000 after acquiring an additional 19 shares during the period. Tealwood Asset Management Inc. grew its position in shares of UnitedHealth Group by 0.4% during the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate's stock valued at $2,626,000 after purchasing an additional 19 shares in the last quarter. Atlas Private Wealth Advisors raised its stake in UnitedHealth Group by 1.1% during the fourth quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate's stock valued at $923,000 after purchasing an additional 19 shares in the last quarter. Prentice Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 0.8% in the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate's stock valued at $1,235,000 after purchasing an additional 19 shares during the last quarter. Finally, Kanawha Capital Management LLC grew its holdings in UnitedHealth Group by 1.4% during the 3rd quarter. Kanawha Capital Management LLC now owns 1,411 shares of the healthcare conglomerate's stock valued at $712,000 after purchasing an additional 20 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.